Want to see GB:BSFA full AI Analyst Report?
BSFA Stock Chart & Stats
1.15 p
-0.05 p(-5.88%)
At close: 4:00 PM EDT
1.15 p
-0.05 p(-5.88%)
Day’s Range― - ―
52-Week Range0.50 p - 4.00 p
Previous CloseN/A
Volume840.17K
Average Volume (3M)4.00M
Market Cap
£2.04M
Enterprise Value-136.50K
Total Cash (Recent Filing)£60.17K
Total Debt (Recent Filing)£482.32K
Price to Earnings (P/E)―
Beta3.78
Next Earnings
Feb 04, 2027EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding203,749,440
10 Day Avg. Volume4,045,015
30 Day Avg. Volume3,998,741
Financial Highlights & Ratios
PEG Ratio0.08
Price to Book (P/B)1.46
Price to Sales (P/S)75.11
P/FCF Ratio-3.90
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Rapid Revenue GrowthStrong revenue scaling indicates improving commercial traction and product adoption. If growth continues, greater revenue density could eventually help absorb the current cost base, although profitability has not yet followed.
Minimal DebtA debt-free balance sheet limits interest obligations and refinancing risk, preserving financial flexibility while the company develops its business. This provides structural resilience compared with highly leveraged biotechnology peers.
Improving Operating Cash BurnThe reduction in operating cash burn suggests some progress in cash management and operating efficiency. Although cash generation remains negative, continued improvement could reduce the pace of external funding required over the medium term.
Bears Say
Persistent UnprofitabilityNegative gross profit shows that current revenue does not cover direct costs, while large net losses indicate an unsustainable earnings structure. The business must improve unit economics and operating leverage before growth can translate into durable profits.
Ongoing Funding DependencePersistent negative operating and free cash flow means the company is not self-funding at its current scale. Continued reliance on financing could dilute shareholders or constrain investment if capital becomes harder to obtain.
Declining Equity BaseA shrinking equity base reduces the financial cushion available to absorb future losses and fund development. Despite minimal debt, continued erosion could weaken resilience and increase dependence on new shareholder capital.
BSF Enterprise PLC News
BSFA FAQ
What was BSF Enterprise PLC’s price range in the past 12 months?
BSF Enterprise PLC lowest share price was 0.50 p and its highest was 4.00 p in the past 12 months.
What is BSF Enterprise PLC’s market cap?
BSF Enterprise PLC’s market cap is £2.04M.
When is BSF Enterprise PLC’s upcoming earnings report date?
BSF Enterprise PLC’s upcoming earnings report date is Feb 04, 2027 which is in 152 days.
How were BSF Enterprise PLC’s earnings last quarter?
BSF Enterprise PLC released its earnings results on Jun 30, 2026. The company reported -0.007 p earnings per share for the quarter.
Is BSF Enterprise PLC overvalued?
According to Wall Street analysts BSF Enterprise PLC’s price is currently Overvalued.
Does BSF Enterprise PLC pay dividends?
BSF Enterprise PLC does not currently pay dividends.
What is BSF Enterprise PLC’s EPS estimate?
BSF Enterprise PLC’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does BSF Enterprise PLC have?
BSF Enterprise PLC has 203,749,440 shares outstanding.
What happened to BSF Enterprise PLC’s price movement after its last earnings report?
BSF Enterprise PLC reported an EPS of -0.007 p in its last earnings report. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of BSF Enterprise PLC?
Currently, no hedge funds are holding shares in GB:BSFA
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
BSF Enterprise PLC
BSF Enterprise PLC is a United Kingdom-based biotech company. The Company develops and commercializes cell-based tissue engineered solutions, including lab-grown leather, cultivated meat, and corneal repair technologies. The principal activity of the Company is to undertake the acquisition of businesses in the biotechnology, marketing and e-commerce sectors.
Technical Analysis
Blue Star Capital
―
Braveheart Investment
―
Pires Investments
―
Primorus Investments
―
Contango Holdings Plc
―








